Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Generic: The growth journey continues - ABG

GENIThird party research11.08.2026, 13.53

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
* We expect growth to return in a seasonally soft quarter
* Estimates unchanged but costs elevated near term
* EV/adj. EBIT of 10/9x '26e/'27e, ~60% below peers


Volume recovery holds

Generic reports its Q2 on 20 August. We think the recovery in Messaging (SMS and related services, 73% of the group's sales) will continue through the quarter, and we estimate sales of SEK 49m, up 10% y-o-y. Q2 is normally the quietest quarter of the year, as Sweden has many public holidays and fewer messages are sent when offices are closed. Some customer groups (logistics in particular) are likely still cautious about spending. At the same time, we think Generic continues to win customers in areas that depend less on the economic cycle, such as e-health, which should gradually tilt sales towards steadier revenue. For Q2 we estimate a gross margin of 44% and adj. EBIT of SEK 9m, for a margin of 19%.


Minor changes to estimates

We leave our estimates broadly unchanged ahead of the report, expecting 8% sales growth for the full year '26e (4% y-o-y in '25e) and an adj. EBIT of SEK 41m, for a margin of 21%. Recruitment and increased use of external resources should keep costs somewhat elevated in the near term, and we see limited room for margin expansion before the mix shift gains scale.


Trading at an EV/adj. EBIT of 10/9x for '26e/'27e

The stock trades at 10x EV/adj. EBIT on '26e and 9x on '27e, ~60% below CPaaS peers, despite higher growth and EBIT margins of 21% (peers averaging ~10%). With over 30% of Swedish municipalities already penetrated and the offering broadening into regions, authorities and private companies, we expect the shift to lift both recurring revenue and gross margins.